Patent · US Active

Treatments for cancer

US8728468B2 · kind B2 · utility

0Cited by
2References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2012
Grant dateMay 20, 2014
Priority date
Expiry dateSep 12, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/475
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods for reducing tumor survival, expansion, and metastasis. In particular, the invention provides methods for reducing melanoma tumor survival, expansion, and metastasis. The invention also provides agents for use in the methods, particularly agents that reduce the level or activity of connective tissue growth factor (CTGF).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.